Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2011

Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, et al. Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis. 2011;31(1):49-60.

Mirchandani D, Roses DF, Inghirami G, Zeleniuch-Jacquotte A, Cangiarella J, Guth A, et al. Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma. Anticancer Res. 2011;31(12):4401-5.

Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M, et al. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov. 2011;1(2):144-57.

Pflueger D, Terry S, Sboner A, Habegger L, Esgueva R, Lin P-, et al. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res. 2011;21(1):56-67.

Grignol V, Fairchild ET, Zimmerer JM, Lesinski GB, Walker MJ, Magro CM, et al. miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. Br J Cancer. 2011;105(7):1023-9.

Niesvizky R, Ely S, Mark T, Aggarwal S, Gabrilove JL, Wright JJ, et al. Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma. Cancer. 2011;117(2):336-42.

Yang GC, Scognamiglio T, Kuhel WI. Fine-needle aspiration of mucin-producing thyroid tumors. Acta Cytol. 2011;55(6):549-55.

Bourgault S, Solomon JP, Reixach N, Kelly JW. Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion. Biochemistry. 2011;50(6):1001-15.

Diaz-Meco MT. Targeting leucine addiction and autophagy in melanoma. Pigment Cell Melanoma Res. 2011;24(4):588-9.

Glezerman IG, M Pietanza C, Miller V, Seshan SV. Kidney tubular toxicity of maintenance pemetrexed therapy. Am J Kidney Dis. 2011;58(5):817-20.